Mapping the RAS Mutation Landscape in Pancreatic Cancer with K-Dense Web
K-Dense Web analyzed global RAS mutation prevalence, drug eligibility, statistics, and the clinical-trial landscape in pancreatic cancer (PDAC).
Blog
Insights & Updates
Explore tutorials, product updates, and insights on AI-powered research automation from the K-Dense team.
Filter by:AllAIARPA-HBenchmarksBiologyBiomarker DiscoveryBiotechCase StudyChemistryClinical TrialsCommunityCompetitive IntelligenceData ScienceDrug DevelopmentDrug DiscoveryDue DiligenceEnterpriseFDAFinanceGBMGPUHealth PolicyHealthcareImmunotherapyInvestment AnalysisK-Dense BYOKK-Dense WebMachine LearningMass SpectrometryMedical DevicesMetabolomicsMultimodalNVIDIANeoantigenOSINTOncologyOpen SourceOpinionPhDPharmaProductProteomicsPublic HealthPublic PolicyReproducibilityResearchResearch FundingResearch PlanningRoboticsScienceScientific Agent SkillsScientific IntegritySecuritySkillsTranslational ResearchTutorialUAPUse Case
Showing 4 posts tagged "Oncology".
From Prompt to Phase III: Biomarker Discovery for Bispecific Antibodies in DLBCL
K-Dense Web integrated 6 databases, ranked 6 candidate biomarkers, and produced Phase III trial design recommendations for CD20xCD3 bispecifics in DLBCL.
From Genomics to Vaccine Strategy: Mapping the PDAC Neoantigen Landscape in a Single Session
K-Dense Web queried 6 databases, modeled KRAS structure, mapped the tumor microenvironment, and built a 36-slide iNeST strategy for PDAC neoantigen vaccines.
The GBM Trial Paradox: 1,913 Trials, Zero Breakthrough Approvals
GBM clinical trial analysis: 1,913 trials, yet zero breakthrough approvals. Three insights explain the gap and where glioblastoma research must go next.